In vitro · 2023
Preclinicalcounts toward this tierPentosan polysulfate sodium promotes redifferentiation to the original phenotype in micromass-cultured canine articular chondrocytes and exerts molecular weight-dependent effects
Wang Y, Sunaga T, Mwale C, Akaraphutiporn E, Kim S, Okumura M · The Journal of Veterinary Medical Science
Chain length changes what the drug does: PPS pushed dedifferentiated chondrocytes back toward the cartilage phenotype — type II collagen, aggrecan and SOX9 up, proteoglycan deposition up — and did so more strongly at higher molecular weight, with the 1,500 Da fraction doing nothing and the 5,000 and 7,000 Da fractions carrying the significant effects; flow cytometry showed no apoptosis or necrosis at any size, although MTT viability fell with concentration and chain length, which the authors read as slowed proliferation. The 7,000 Da fraction also raised type I collagen, the fibrocartilage marker.
- Population
- Micromass-cultured articular chondrocytes from five dogs
- Intervention
- PPS fractions of 1,500 to 7,000 Da
- Comparator
- Untreated micromass cultures
- Limitations
- Cell culture, canine cells from five dogs, and the largest fraction's type I collagen rise is a caveat the anabolic reading has to carry; the practical implication is that PPS preparations differing in size distribution are not interchangeable. JST-funded; no conflicts declared.
Cited by
1 entry references this study
- Pentosan polysulfate (PPS)PROM.
Peptides → Clinically studied
Evidence for that entry
Promising